Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-14

Clinical Trial Update: A Clinical Study of RSS0343 in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 study of RSS0343 in healthy subjects is currently recruiting. The trial lists Non-cystic Fibrosis Bronchiectasis as the associated condition.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RSS0343

Snippet

Sponsor: Reistone Biopharma Company Limited | Conditions: Non-cystic Fibrosis Bronchiectasis | Phase 1 | Status: RECRUITING